Monday, October 5, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 4, 2026

ZenaTech informa un aumento interanual del 640 % en sus ingresos del primer trimestre de 2026, impulsado por su división de drones

View original at globenewswire.com
ZenaTech informa un aumento interanual del 640 % en sus ingresos del primer trimestre de 2026, impulsado por su división de drones La posición de caja y el financiamiento respaldan la ejecución continua de las hojas de ruta de dron, June 03, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • With 26 DaaS locations operating across ten US states, Canada, UK, Ireland, UAE, and Australia, and with continued advancement of the defense technology portfolio, the fundamental business trajectory remains solid and will continue growing as demand for integrated drone services and solutions accelerates in 2026

    60% confidence

  • ZenaTech is exploring opportunities with the US Department of War (DoD) including initiatives supported by the Office of Strategic Capital

    60% confidence

  • Total Q1 2026 revenue was CAD 8.4 million, representing approximately 640% growth over Q1 2025

    60% confidence

  • Management believes ZenaTech is well positioned to continue growing during 2026, with the DaaS segment benefiting from a full year of revenue contribution from 2025 acquisitions

    60% confidence

  • Q1 2026 was another record quarter for ZenaTech, executing the strategy of acquiring traditional surveying companies and experienced licensed operators with established customer bases, migrating them to drone-based automation through the Drone as a Service model

    60% confidence

  • ZenaTech maintained CAD 15 million in cash and marketable securities at quarter end, plus additional growth capital flexibility through recent financing initiatives, and is well positioned to continue executing organic growth and strategic acquisitions in DaaS and other business areas

    60% confidence

  • SaaS segment revenue decline in Q1 2026 vs Q1 2025 was primarily due to software license renewal timing

    60% confidence

Data points we hold from this source

ZenaTech, Inc. · net income-143031 CAD
ZenaTech, Inc. · employee count26 daas_locations
ZenaTech, Inc. · revenue589857 CAD
ZenaTech, Inc. · cash15.0 million_CAD
ZenaTech, Inc. · backlog109.5 million_CAD
ZenaTech, Inc. · backlog100 million_CAD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com
ZenaTech informa un aumento interanual del 640 % en sus ingresos del primer trimestre de 2026, impulsado por su división de drones — Source | Via News | Via News